This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1978.
Company Filing History:
Years Active: 1978
Title: Wolfgang Steingross: Innovator in Cancer Research
Introduction
Wolfgang Steingross is a notable inventor based in Viernheim, Germany. He has made significant contributions to the field of cancer research through his innovative work. His dedication to developing effective treatments has led to the creation of a unique patent that showcases his expertise.
Latest Patents
Steingross holds a patent for 4-Imino-1,3-diazabicyclo-(3.1.0)-hexan-2-one, which serves as a cancerostat. This compound exhibits cancerostatic and immuno-stimulant activity. The production process involves cyclized 1-carboxamido-2-cyanoaziridine in an anhydrous polar organic solvent, utilizing a catalytic amount of an alkali. This innovative approach highlights his commitment to advancing cancer treatment options.
Career Highlights
Throughout his career, Wolfgang Steingross has been associated with Boehringer Mannheim GmbH, where he has contributed to various research initiatives. His work has been instrumental in developing new therapeutic strategies aimed at combating cancer. His patent reflects his innovative thinking and dedication to improving patient outcomes.
Collaborations
Steingross has collaborated with esteemed colleagues, including Wolfgang Kampe and Uwe Bicker. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of cancer research.
Conclusion
Wolfgang Steingross is a prominent figure in the realm of cancer research, with a patent that underscores his innovative contributions. His work continues to inspire advancements in cancer treatment, showcasing the importance of research and collaboration in the scientific community.